ATE363485T1 - BENZOTHIENO(3,2-C)PYRIDINES AS ALPHA2 ANTAGONISTS - Google Patents

BENZOTHIENO(3,2-C)PYRIDINES AS ALPHA2 ANTAGONISTS

Info

Publication number
ATE363485T1
ATE363485T1 AT99947469T AT99947469T ATE363485T1 AT E363485 T1 ATE363485 T1 AT E363485T1 AT 99947469 T AT99947469 T AT 99947469T AT 99947469 T AT99947469 T AT 99947469T AT E363485 T1 ATE363485 T1 AT E363485T1
Authority
AT
Austria
Prior art keywords
benzothieno
pyridines
alpha2 antagonists
alpha2
antagonists
Prior art date
Application number
AT99947469T
Other languages
German (de)
Inventor
Ludo Edmond Josephine Kennis
Serge Maria Aloysius Pieters
Francois Paul Bischoff
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE363485T1 publication Critical patent/ATE363485T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT99947469T 1998-10-06 1999-10-01 BENZOTHIENO(3,2-C)PYRIDINES AS ALPHA2 ANTAGONISTS ATE363485T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98203363 1998-10-06

Publications (1)

Publication Number Publication Date
ATE363485T1 true ATE363485T1 (en) 2007-06-15

Family

ID=8234188

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99947469T ATE363485T1 (en) 1998-10-06 1999-10-01 BENZOTHIENO(3,2-C)PYRIDINES AS ALPHA2 ANTAGONISTS

Country Status (28)

Country Link
US (2) US6426350B1 (en)
EP (1) EP1117667B1 (en)
JP (1) JP4580555B2 (en)
KR (1) KR20010071828A (en)
CN (1) CN1158287C (en)
AR (1) AR023678A1 (en)
AT (1) ATE363485T1 (en)
AU (1) AU760226B2 (en)
BG (1) BG64625B1 (en)
BR (1) BR9913110A (en)
CA (1) CA2346084C (en)
CZ (1) CZ20011103A3 (en)
DE (1) DE69936219T2 (en)
EE (1) EE04835B1 (en)
ES (1) ES2288025T3 (en)
HK (1) HK1039113A1 (en)
HU (1) HUP0103612A3 (en)
ID (1) ID28280A (en)
IL (2) IL142442A0 (en)
NO (1) NO20011309L (en)
NZ (1) NZ509911A (en)
PL (1) PL347184A1 (en)
RU (1) RU2222542C2 (en)
SK (1) SK4312001A3 (en)
TR (1) TR200100954T2 (en)
TW (1) TWI251595B (en)
UA (1) UA70334C2 (en)
WO (1) WO2000020422A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE494000T1 (en) * 2002-03-08 2011-01-15 Max Planck Gesellschaft USE OF EGFR TRANSACTIVATION INHIBITORS FOR HUMAN CANCER
CA2480266C (en) * 2002-04-03 2011-07-12 Orion Corporation Use of an alpha2-adrenoreceptor antagonist for cns-related diseases
EP1757605A4 (en) 2004-04-12 2007-12-19 Taisho Pharmaceutical Co Ltd Cyclic amine compound

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3752820A (en) * 1972-03-20 1973-08-14 Colgate Palmolive Co Substituted-1,2,3,4-tetrahydrobenzothieno(3,2-c)pyridine derivatives
FR2570701B1 (en) * 1984-09-27 1987-05-22 Synthelabo FURO (3,2-C) PYRIDINES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines
EP0339959A3 (en) * 1988-04-27 1991-03-20 Glaxo Group Limited Lactam derivatives
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
ATE247114T1 (en) * 1994-09-12 2003-08-15 Lilly Co Eli SEROTONERGIC MODULATORS
JP3274579B2 (en) * 1995-01-12 2002-04-15 住友製薬株式会社 Agent for treating psychiatric symptoms associated with cerebrovascular disorders
UA52681C2 (en) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Derivatives of 1,2,3,4-tetrahydro-benzofuro [3,2,-c] pyridine

Also Published As

Publication number Publication date
DE69936219D1 (en) 2007-07-12
JP4580555B2 (en) 2010-11-17
PL347184A1 (en) 2002-03-25
BG105331A (en) 2001-11-30
UA70334C2 (en) 2004-10-15
SK4312001A3 (en) 2001-12-03
AU760226B2 (en) 2003-05-08
CA2346084A1 (en) 2000-04-13
TR200100954T2 (en) 2001-12-21
ID28280A (en) 2001-05-10
EP1117667B1 (en) 2007-05-30
WO2000020422A1 (en) 2000-04-13
US6426350B1 (en) 2002-07-30
HK1039113A1 (en) 2002-04-12
CZ20011103A3 (en) 2001-12-12
IL142442A (en) 2006-10-05
EE04835B1 (en) 2007-06-15
EP1117667A1 (en) 2001-07-25
HUP0103612A3 (en) 2003-03-28
KR20010071828A (en) 2001-07-31
DE69936219T2 (en) 2008-02-07
NZ509911A (en) 2002-09-27
EE200100206A (en) 2002-06-17
US20020169178A1 (en) 2002-11-14
TWI251595B (en) 2006-03-21
IL142442A0 (en) 2002-03-10
CN1321159A (en) 2001-11-07
ES2288025T3 (en) 2007-12-16
HUP0103612A2 (en) 2002-01-28
AR023678A1 (en) 2002-09-04
RU2222542C2 (en) 2004-01-27
NO20011309D0 (en) 2001-03-15
CA2346084C (en) 2010-01-26
CN1158287C (en) 2004-07-21
JP2002526546A (en) 2002-08-20
BG64625B1 (en) 2005-09-30
US6774129B2 (en) 2004-08-10
BR9913110A (en) 2001-05-08
NO20011309L (en) 2001-03-15
AU6089999A (en) 2000-04-26

Similar Documents

Publication Publication Date Title
DE60202200D1 (en) IMIDAZO [1,2-A] pyridine derivatives as MGLUR5 antagonists
ATE355841T1 (en) USE OF PYRAZOLO (3,4-B)PYRIDINE AS A CYCLINE-DEPENDENT KINASE INHIBITOR
ATE249437T1 (en) SUBSTITUTED PYRIDINES AS SELECTIVE CYCLOOXYGENASE INHIBITORS
ATE381565T1 (en) 1,3,8-TRIAZA-SPIRO 4,5 DECAN-4-ONE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS
DE69904602T2 (en) SUBSTITUTED 1,8-NAPHTHYRIDIN-4 (1H) -ONE AS PHOSPHODIESTERASE 4-INHIBITORS
PT1087971E (en) PYRROLE [2,3-D] PYRIDINE COMPOUNDS
CU23053A3 (en) 1,2,3,4-TETRAHYDROQUINLINES 2-SUBSTITUTED 4-AMINO SUBSTITUTED
EP0640084A4 (en) 6-AMINO SUBSTITUTED IMIDAZO 4,5-b]PYRIDINES AS ANGIOTENSIN II ANTAGONISTS.
ATE293618T1 (en) 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTI-TUMOR AGENTS
DE59702034D1 (en) 2-aryl substituted pyridines
DE69431604D1 (en) BENZOFURANE DERIVATIVES AS TACHYKININE ANTAGONISTS
NZ318436A (en) Quinolein-2(1h)-one derivatives substituted with a 4-(thieno[3,2-c]pyridin-4-yl)piperazine-1-yl or 4-(4-fluorobenzoyl)piperidin-1-yl group as serotonin antagonists
DE69714265T2 (en) TETRAHYDROCHINOLIN DERIVATIVES AS EAA ANTAGONISTS
ATE270294T1 (en) 1,2,3,4-TETRAHYDRO-BENZOFURO(3,2-C)PYRIDINE DERIVATIVES
TR199901381A3 (en) Diaza-spiro [3,5] nonane derivatives.
ATE224391T1 (en) SUBSTITUTED IMIDAZO(1,2A)AZINE AS SELECTIVE INHIBITORS OF COX-2
ATE232869T1 (en) TRICYCLIC DELTA3-PIPERIDINES AS ALPHA2 ANTAGONISTS
ID27845A (en) TETRAHIDROKUILINA DECREASED AS GLISILINA ANTAGONISTS
ATE363485T1 (en) BENZOTHIENO(3,2-C)PYRIDINES AS ALPHA2 ANTAGONISTS
ATE258935T1 (en) FURO(3,2-B)PYRIDINES AS 5-HT1F AGONISTS
ATE262904T1 (en) ORAL COMPOSITIONS CONTAINING 8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDYLIDEN)-5H-B NZO(5,6)CYCLOHEPTA(1,2-B)PYRIDINE
DE69735811D1 (en) PIPERAZINODERIVATES AS NEUROKININE ANTAGONISTS
DE60001054T2 (en) TRICYCLIC PYRIDINE N-OXIDE VASOPRESSIN AGONISTS
ID30349A (en) BENZO (5,6) CYCLOHEPTA (1,2-B) PYRIDINE TO BLOCK TRANSFERASE FARNESIL PROTEIN
EE200000029A (en) 5-Substituted-3-Oxadiazolyl-1,6-naphthyridin-2 (1H) -one Derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties